Delivery Order SPE2DB24D2205-SPE2DB24FDWND

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) pens. The $1,510.62 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) prefilled pens. The award has a ceiling value of $24,079.84 and an ultimate completion date of September 17, 2024. The contract is a delivery order with a firm fixed-price pricing type, and there is no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) injection pens. The contract is a $6,538.28 firm-fixed-price delivery order with a completion date of September 6, 2024. The contract is not a set-aside award. AmerisourceBergen, through its Corporate Office division, will provide the Humira medication to support military treatment facilities and other government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens. The $11,226.92 firm-fixed-price delivery order has a completion date of June 10, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract, valued up to $1,385.37, is for the delivery of Humira Pen 40 mg/0.8 mls, a pharmaceutical product. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) PEN 80 MG/0.8 MLS. The $11,038.95 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,380.78, is for the delivery of HUMIRA(CF) PEN 80 MG/0.8 MLS, a pharmaceutical product. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Humira Pen 40 mg/0.8 mL medical supplies. The ceiling value of this Delivery Order contract is $2,810.34, and it has a firm fixed price pricing type. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) autoinjector pens. The award, a Delivery Order valued at $42,560.00, has a firm fixed price and is not set aside for any specific business category. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, through its Corporate Office division, will deliver the Humira pens to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) autoinjector pens. The contract, valued at $1,761.66, is a delivery order on an existing Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp). This IDC, worth up to $999,999,999.00, serves as the primary vehicle for Cencora,...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWND
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (Adalimumab) pens to the government. The award, valued at $8,273.50, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen's expertise in pharmaceutical distribution and its extensive supply chain network enable it to efficiently fulfill this and other government contracts for critical medical products.

Generated 10/7/24, 10:56 AM